Sign in Register

Zantac (ranitidine HCl)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

Generic name: ranitidine HCl

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Zantac

Intelligence content is not available yet.

Indications

The following indications are listed for Zantac:

  • Duodenal Ulcer
  • Erosive Esophagitis
  • Gastric Hypersecretion With Systemic Mastocytosis
  • Gastric Ulcer
  • Gastroesophageal Reflux Disease
  • Heartburn
  • Maintenance Of Healing Duodenal Ulcer
  • Maintenance Of Healing Erosive Esophagitis
  • Maintenance Of Healing Gastric Ulcer
  • Multiple Endocrine Neoplasia
  • Pathological Gastric Acid Hypersecretory Condition
  • Zollinger-Ellison Syndrome

Also known as: Adenomatosis Partial Multiple Endocrine, Brash, Gastric Acid Hypersecretory Conditions Due To Disease, Gastro-Esophageal Reflux, Ge Reflux Disease, Maintenance Of Healing Du, Multiple Endocrine Adenoma, Pancreatic Ulcerogenic Tumor Syndrome, Pathological Gastric Acid Hypersecretory States, Pathological Hypersecretion State, Pathological Hypersecretory Condition, Pyrosis, Systemic Mast Cell Disease With Gastric Hypersecretion, Z-E Syndrome.

Dosing

No dosing information is available for this tab.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

No ICD codes are available for this drug.

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a 5-digit ZIP code. Searching does not change your profile.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data